Live feed
Filing
SC 13G
SC 13G0001193125-18-043019·Lundbeckfond Invest A/S
Schedule 13G ownership disclosure
Spero Therapeutics Inc
Security class unavailable · CUSIP: 84833T103
Event date: 2017-11-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-043019
- Form type
- SC 13G
- Filer
- Lundbeckfond Invest A/S
- CIK
- CIK 1591046
- Filed
- Feb 14, 2018
- Reporting period
- Nov 06, 2017
- Description
- Schedule 13G beneficial ownership